Medidata Solutions Inc (MDSO) is Resumed by Needham to Buy, Price Target at $55

Medidata Solutions Inc (MDSO) was Resumed by Needham to “Buy” and the brokerage firm has set the Price Target at $55. Needham advised their investors in a research report released on Jul 11, 2016.

Many Wall Street Analysts have commented on Medidata Solutions Inc. Medidata Solutions Inc was Downgraded by Jefferies to ” Underperform” on Apr 26, 2016. Medidata Solutions Inc was Initiated by Leerink Partners to “Mkt Perform” on Apr 26, 2016. Company shares were Reiterated by Topeka Capital Markets on Apr 22, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $44 .

On the company’s financial health, Medidata Solutions Inc reported $0.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $0.18. The company had revenue of $104.20 million for the quarter, compared to analysts expectations of $103.27 million. The company’s revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.17 EPS.

Medidata Solutions Inc opened for trading at $47.38 and hit $48.285 on the upside on Friday, eventually ending the session at $48.17, with a gain of 2.42% or 1.14 points. The heightened volatility saw the trading volume jump to 5,21,844 shares. Company has a market cap of $2,760 M.

In a different news, on Jul 6, 2016, Tarek Sherif (Chairman & CEO) sold 7,500 shares at $46.35 per share price. According to the SEC, on Jun 30, 2016, Steven Isaac Hirschfeld (Vice Chairman) sold 10,000 shares at $45.66 per share price. On Jun 13, 2016, Vries Glen Michael De (President) sold 7,500 shares at $47.66 per share price, according to the Form-4 filing with the securities and exchange commission.

Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.

Medidata Solutions Inc

Leave a Reply

Medidata Solutions Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medidata Solutions Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.